Oct 27, 2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the In Vitro Diagnostic Testing Market.

It was estimated prior to this unanticipated outbreak that the In Vitro Diagnostic Testing Market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019.  Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers. In the infectious diseases segment, most of the currently available tests detect a single pathogen, or an antibiotic resistance gene. However, if a patient presents with general symptoms of a respiratory infection, or with symptoms of a gastrointestinal infection or some other type of infection, there are several different pathogens that may have caused the infection. However, syndromic testing is soon becoming a reality where multiple pathogens can be detected, increasing the chances of detection, bringing down the cost of testing and directly impacting the DALY of patients.

Key Players:

Key players operating in the global In Vitro Diagnostic Testing market are-

• Roche Diagnostics Limited (Switzerland),

• Siemens Healthineers (Germany),

• Danaher Corporation (US),

• Abbott Laboratories (US),

• Thermo Fisher Scientific (US)

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The In Vitro Diagnostic Testing analysis report discusses the following heads in great detail:

• Market structure: Overview, industry life cycle analysis, supply chain analysis

• COVID-19 Impact Assessment

• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis

• Market trend and forecast analysis

• Market segment trend and forecast

• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.

• Attractive market segments and associated growth opportunities

• Emerging trends

• Strategic growth opportunities for the existing and new players

• Key success factors